AdBio Partners

Get funding

AdBio Partners invests in and develop the most innovative early-stage startups in life sciences in Europe.

Use:
Date closing: -
Amount: -
Industry focus: Health;
Total budget: 86M £
Entity type: Venture Capital
Vertical focus: All
Website: https://adbio.partners/

Status:
Open
Funding type:
Geographic focus: Europe;
Public/Private: Private
Stage focus: pre-seed; Seed;
Applicant target: Startup;

Add a Review Send question

Overview

AdBio partners (formerly Advent France Biotechnology) is a venture capital firm investing in early stage life sciences companies in Europe.

They explore new territories to source and develop breakthrough medical discoveries across various therapeutic areas and drive inventive European life sciences startups towards success.

They work with leading research institutions and well-established technology transfer offices in Europe, with the support of a strong network of scientific & industrial partners and international VC syndicates

AdBio partners has built a strong team of experts with extensive business, scientific and financial expertise. They firmly believe this strategy enables the early identification of the most promising therapeutic innovations to kick-start and grow sustainable startups together with scientific founders and academic institutions.

AdBio partners has raised a total of $185.2M across 2 funds, their latest being Advent France Biotechnology Fund II. This fund was announced on Sep 30, 2021 and raised a total of £86M.

Portfolio: Alderaan, Diogenx, Integra, ARTHex.

Last updated on 2025-08-12 11:59